🇰🇷 Ultravate in South Korea

MFDS authorised Ultravate on 17 December 1990

Marketing authorisation

MFDS — authorised 17 December 1990

  • Marketing authorisation holder: RANBAXY
  • Status: likely_approved

Ultravate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Ultravate approved in South Korea?

Yes. MFDS authorised it on 17 December 1990.

Who is the marketing authorisation holder for Ultravate in South Korea?

RANBAXY holds the South Korean marketing authorisation.